A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.

Clinical trial NCT07280858 · RECRUITING

Trial details

NCT number: NCT07280858
Sponsor: SK Bioscience Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Participants Sarbecovirus

Start date: 2026-01-28
Primary completion: 2026-12-09
Enrollment: 368

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.